News | April 27, 2009

Varian to Show Brachytherapy, IMRT, SBRT at AUA Meeting

April 27, 2009 - Varian Medical Systems is showcasing the its full spectrum of prostate cancer treatment technologies, including brachytherapy, IMRT and SBRT, at the American Urological Association (AUA) Meeting at McCormick Place in Chicago from April 25-30.

"At the AUA meeting, we'll be exhibiting our latest solutions for high-dose-rate brachytherapy, planning for low-dose brachytherapy with permanent seed implants, 3D conformal radiotherapy, intensity-modulated radiotherapy (IMRT), and stereotactic body radiotherapy (SBRT)," said Calvin Huntzinger, MS, senior director, Varian Surgical Sciences. Each is a different approach to targeting prostate tumors with radiation.

Varian recently produced a clinical perspectives paper entitled “Early-stage prostate cancer treatment alternatives,” highlighting research that contrasts these and other approaches to prostate cancer treatment.

Varian will be showcasing the following radiotherapy solutions at the AUA meeting:

- The VariSource and GammaMed lines of HDR brachytherapy afterloaders, a computer-controlled device for guiding a needle or catheter as it places a radiation source directly into a tumor and holds it there for a prescribed period of time while the dose is delivered.
- VariSeed brachytherapy treatment planning software, which facilitates the permanent implantation of tiny radioactive seeds, each the size of a grain of rice, directly into the prostate.

Also showcased will be the Novalis Tx platform for image-guided radiotherapy and radiosurgery, a suite of tools made by Varian and BrainLAB for delivering external beam radiotherapies, including 3D conformal, IMRT, RapidArc radiotherapy and SBRT.

Novalis Tx can also deliver RapidArc radiotherapy, making it possible to complete an IMRT or SBRT treatment very quickly by dosing the entire tumor volume with a single rotation of the treatment machine around the patient.

The American Urological Association Meeting will take place at McCormick Place in Chicago, April 25-30.

For more information: www.varian.com

Related Content

ASTRO and ASCO Launch New Cancer Care Quality Registry
News | Radiation Therapy | January 22, 2018
January 22, 2018 — A registry that tracks the quality of medical care provided to patients receiving cancer treatment
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
Overlay Init